Invesco Ltd. 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 7:18 pm Sale | 2023-02-14 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 313,974 0.400% | -3,800,057 (-92.37%) | Filing |
| 2022-02-10 11:32 am Purchase | 2022-02-09 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 4,114,031 5.800% | 546,446 (+15.32%) | Filing |
| 2021-02-12 3:34 pm Purchase | 2021-02-12 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 3,567,585 6.200% | 229,696 (+6.88%) | Filing |
| 2020-02-13 3:13 pm Purchase | 2020-02-13 | 13G | Veracyte, Inc. VCYT | Invesco Ltd. IVZ | 3,337,889 6.800% | 3,337,889 (New Position) | Filing |